Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

Saved in:
Bibliographic Details
Title: Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Authors: Pietropaolo M (AUTHOR), Yu S (AUTHOR), Libman IM (AUTHOR), Pietropaolo SL (AUTHOR), Riley K (AUTHOR), LaPorte RE (AUTHOR), Drash AL (AUTHOR), Mazumdar S (AUTHOR), Trucco M (AUTHOR), Becker DJ (AUTHOR)
Source: Pediatric Diabetes. Dec2005, Vol. 6 Issue 4, p184-192. 9p.
URL: 19643333
Database: Academic Search Ultimate
Description
ISSN:1399543X
DOI:10.1111/j.1399-543x.2005.00127.x